본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Pattern of practice for postoperative management of endometrial cancer in Korea: a survey by the Korean Gynecologic Oncology Group and the Korean Radiation Oncology Group (KGOG 2028-KROG 2104) Joo-Young Kim
(Radiological Science?Branch)

Lee Sung Uk
(Department of Radiation oncology)
. Pattern of practice for postoperative management of endometrial cancer in Korea: a survey by the Korean Gynecologic Oncology Group and the Korean Radiation Oncology Group (KGOG 2028-KROG 2104). JOURNAL OF GYNECOLOGIC ONCOLOGY. 2023-03-22; 2023; 34(4):e54~. IF 3.9 (2022)
IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis Park Jong Bae
(Department of Cancer Biomedical Science)

Lin weiwei
(NCCGCSP Research and Development Business Foundati)
. IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis. NATURE COMMUNICATIONS. 2023-03-22; 2023; 14(1):1578~. IF 16.6 (2022)
Hybrid solid mesh structure for electron beam melting customized implant to treat bone cancer
()

Park Jong Woong
(Surgical Oncology Branch)
. Hybrid solid mesh structure for electron beam melting customized implant to treat bone cancer. INTERNATIONAL JOURNAL OF BIOPRINTING. 2023-03-21; 2023; 9(4):716~. IF 8.4 (2022)
Association between depressive symptoms and the risk of all-cause and cardiovascular mortality among US adults
()

Lee Seo Yoon
(Department of Psychiatry & Behavioral Science)
. Association between depressive symptoms and the risk of all-cause and cardiovascular mortality among US adults. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2023-03-21; 2023; 125:110755~. IF 5.6 (2022)
Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation Kim, Sun Shin
(Targeted Therapy Branch)

Hwang, Mihwa
(Targeted Therapy Branch)
. Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation. BIOMOLECULES & THERAPEUTICS. 2023-03-21; 2023; 31(5):559~565. IF 3.7 (2022)
A Randomized Phase II Study of Irinotecan Plus Cisplatin with or without Simvastatin in Ever-Smokers with Extended Disease Small Cell Lung Cancer Han Ji-Youn
(Anticancer Resistance Branch )

Lee Young Joo
(Targeted Therapy Branch)
. A Randomized Phase II Study of Irinotecan Plus Cisplatin with or without Simvastatin in Ever-Smokers with Extended Disease Small Cell Lung Cancer. CANCER RESEARCH AND TREATMENT. 2023-03-20; 2023; 55(3):885~893. IF 4.6 (2022)
Characteristics and clinical course of thyroid abnormalities arisen in long term survivors of childhood cancer Park Hyeon Jin
(Department of Pediatrics)

Jin Hye Young
(Department of Pediatrics)
. Characteristics and clinical course of thyroid abnormalities arisen in long term survivors of childhood cancer. BMC PEDIATRICS. 2023-03-18; 2023; 23(1):124~. IF 2.4 (2022)
Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
()

Cha Yongjun
(Bioinformatics Branch)
. Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers. CANCER RESEARCH AND TREATMENT. 2023-03-14; 2023; 55(2):367~384. IF 4.6 (2022)
Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma
()

Harim Koo
(Department of Cancer Biomedical Science)
. Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma. GENOME MEDICINE. 2023-03-13; 2023; 15(1):16~. IF 12.3 (2022)
Surgical outcomes in patients with low-risk papillary thyroid microcarcinoma from MAeSTro study: Immediate operation versus delayed operation following active surveillance Jung Yuh Seog
(Center for Thyroid Cancer)


()
. Surgical outcomes in patients with low-risk papillary thyroid microcarcinoma from MAeSTro study: Immediate operation versus delayed operation following active surveillance. ANNALS OF SURGERY. 2023-03-13; 2023; 278(5):e1087~e1095. IF 10.1 (2022)